Type of Care:
Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Hospital inpatient/24-hour hospital inpatient Outpatient
Facility Type:
Psychiatric hospital
Pharmacotherapies:
Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Thiothixene Trifluoperazine Aripiprazole Asenapine Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Dialectical behavior therapy Group therapy Individual psychotherapy Abnormal involuntary movement scale
Facility Operation (e.g., Private, Public):
State government
Special Programs/Groups Offered:
Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
TB screening Metabolic syndrome monitoring Laboratory testing
Recovery Support Services:
Housing services Mentoring/peer support
Facility Smoking Policy :
Smoking permitted in designated area
Age Groups Accepted:
Young Adults Adults Seniors
Facility Vaping Policy:
Vaping permitted in designated area
Ancillary Services:
Assertive community treatment Assisted Outpatient Treatment Court-ordered outpatient treatment Family psychoeducation Psychosocial rehabilitation services Supported housing Case management service Suicide prevention services